ElenaGabrielaChioreanMD

Clinical Trials

• Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer Start of enrollment: 2005 May 01

  Terminated

  Phase 2

• Metabolomics-Based Detection of Colorectal Cancer Start of enrollment: 2007 Jul 01

  Completed

• Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas Start of enrollment: 2007 Sep 01

  Terminated

  Phase 2

• Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors Start of enrollment: 2008 Jan 23

  Completed

  Phase 1

• Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps Start of enrollment: 2009 Jan 01

  Completed

• Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18

  Completed

  Phase 2

• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01

  Active, not recruiting

  Phase 3

• Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Start of enrollment: 2010 Oct 15

  Completed

  Phase 2

• Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer Start of enrollment: 2011 Jun 01

  Withdrawn

  Phase 2

• Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2013 Apr 01

  Completed

  Phase 1

• Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer Start of enrollment: 2013 Apr 01

  Terminated

  Phase 2

• Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer Start of enrollment: 2015 Nov 05

  Completed

  Phase 1

• Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer Start of enrollment: 2019 May 10

  Active, not recruiting

  Phase 3

• Join now to see all